Stability of mefenamic acid in the inclusion complex with β-cyclodextrin in the solid phase

被引:16
作者
Hladon, T [1 ]
Pawlaczyk, J [1 ]
Szfran, B [1 ]
机构
[1] Karol Marcinkowski Univ Med Sci, Dept Inorgan & Analyt Chem, PL-60780 Poznan, Poland
关键词
beta-cyclodextrin complex; mefenamic acid; X-ray and thermogravimetric analyses; complex stability constants; stability studies;
D O I
10.1023/A:1008048612736
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The inclusion complex of mefenamic acid with beta-cyclodextrin was obtained by the method of coprecipitation from diethyl ether. The product was identified by the thermogravimetric and X-ray methods. The complex stability constants were determined by the potentiometric method. The effect of beta-CD on the solubility and stability of mefenamic acid was analysed.
引用
收藏
页码:497 / 506
页数:10
相关论文
共 11 条
[1]  
Ammar HO, 1997, PHARMAZIE, V52, P376
[2]  
DANYSZ A, 1994, PODSTAWY FARMAKOLOGI
[3]  
DUCHENE D, 1990, ACTA PHARM TECHNOL, V36, P1
[4]  
KOSTKOWSKI W, 1994, FARMAKOLOGIA
[5]   SOLVENT EFFECTS ON CHEMICAL PROCESSES .10. SOLUBILITY OF ALPHA-CYCLODEXTRIN IN BINARY AQUEOUS-ORGANIC SOLVENTS - RELATIONSHIP TO SOLID-PHASE COMPOSITION [J].
LEITERMAN, RV ;
MULSKI, MJ ;
CONNORS, KA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (11) :1272-1275
[6]   THE EFFECT OF CYCLODEXTRINS ON THE SOLUBILITY AND STABILITY OF MEDROXYPROGESTERONE ACETATE AND MEGESTROL-ACETATE IN AQUEOUS-SOLUTION [J].
LOFTSSON, T ;
BALDVINSDOTTIR, J ;
SIGURDARDOTTIR, AM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 98 (1-3) :225-230
[7]  
Loftsson T, 1997, PHARMAZIE, V52, P783
[8]   Inclusion of methoxybutropate in beta- and hydroxypropyl beta-cyclodextrins: Comparison of preparation methods [J].
Palmieri, GF ;
GalliAngeli, D ;
Giovannucci, G ;
Martelli, S .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (01) :27-37
[9]   KOMPLEXONE .4. DIE ACIDITAT UND DIE ERDALKALIKOMPLEXE DER ANILIN-DIESSIGSAURE UND IHRER SUBSTITUTIONSPRODUKTE [J].
SCHWARZENBACH, G ;
WILLI, A ;
BACH, RO .
HELVETICA CHIMICA ACTA, 1947, 30 (05) :1303-1320
[10]  
TORRESLABANDEIRA JJ, 1993, EUR J PHARM BIOPHARM, V39, P255